{"id":"cocaine-n-acetylcysteine","safety":{"commonSideEffects":[{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Rash"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Cocaine causes acute oxidative stress and depletion of the antioxidant glutathione in tissues, particularly in the brain and cardiovascular system. N-acetylcysteine (NAC) is a glutathione precursor that restores cellular antioxidant capacity and reduces reactive oxygen species, thereby mitigating cocaine-related cellular damage and potentially reducing addiction-related neurobiological changes.","oneSentence":"N-acetylcysteine replenishes glutathione stores and provides antioxidant protection to counteract cocaine-induced oxidative stress and toxicity.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:40:59.702Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cocaine use disorder and cocaine toxicity mitigation"}]},"trialDetails":[{"nctId":"NCT05610072","phase":"EARLY_PHASE1","title":"Behavioral Effects of Drugs (Inpatient): 43 (Opioids, Cocaine, n-Acetylcysteine)","status":"RECRUITING","sponsor":"William Stoops","startDate":"2022-12-15","conditions":"Cocaine Use Disorder, Opioid Use Disorder, Stimulant Use Disorder","enrollment":24},{"nctId":"NCT04155632","phase":"PHASE2","title":"Neurocircuit Strategy to Decrease Cocaine Cue Reactivity","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2020-12-18","conditions":"Cocaine-Related Disorders","enrollment":32},{"nctId":"NCT02982876","phase":"NA","title":"Airway Stents for Excessive Dynamic Airway Collapse","status":"COMPLETED","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2016-12","conditions":"Tracheobronchomalacia, Excessive Dynamic Airway Collapse","enrollment":50},{"nctId":"NCT03423667","phase":"PHASE2","title":"Efficacy of N-acetylcysteine on the Craving Symptoms of Abstinent Hospitalized Patients With Cocaine Addiction","status":"TERMINATED","sponsor":"Salvatore Campanella","startDate":"2019-03-01","conditions":"Cocaine Addiction","enrollment":33},{"nctId":"NCT01209455","phase":"NA","title":"Mechanisms of N-acetylcysteine Mediated Vascular Adverse Effects","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2011-01-03","conditions":"Poisoning","enrollment":24},{"nctId":"NCT02124941","phase":"PHASE1","title":"Glutamate-Glutamine Cycling (VCYC) During Cocaine Abstinence Using 1H-MRS","status":"COMPLETED","sponsor":"Yale University","startDate":"2014-02","conditions":"Cocaine Dependence, Healthy","enrollment":6},{"nctId":"NCT02994875","phase":"EARLY_PHASE1","title":"Functional Magnetic Resonance Imaging of N-acetylcysteine in Cocaine Dependence","status":"COMPLETED","sponsor":"Yale University","startDate":"2016-05","conditions":"Cocaine Dependence","enrollment":21},{"nctId":"NCT03556371","phase":"PHASE2","title":"Evaluation of N-Acetylcysteine Efficacy to Reduce the Craving and to Prolong Abstinence Time of Coca Paste","status":"COMPLETED","sponsor":"University of Concepcion, Chile","startDate":"2018-04-09","conditions":"Cocaine-Related Disorders","enrollment":140},{"nctId":"NCT00218491","phase":"PHASE2","title":"Effectiveness of N-Acetylcysteine (NAC) in Treating Cocaine Dependent Individuals - 1","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2005-11","conditions":"Cocaine Dependence","enrollment":111},{"nctId":"NCT01392092","phase":"","title":"Effects of N-acetylcysteine on Brain Chemistry and Behavior in Cocaine Abusers (NAC)","status":"COMPLETED","sponsor":"Wayne State University","startDate":"2011-07","conditions":"Cocaine Abuse or Dependence, Cocaine Related Disorders","enrollment":16},{"nctId":"NCT03018236","phase":"PHASE4","title":"Effect of N-acetylcysteine on Alcohol and Cocaine Use Disorders: A Double-Blind Randomized Controlled Trial.","status":"UNKNOWN","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2017-01","conditions":"Cocaine Addiction, Alcohol Addiction","enrollment":100},{"nctId":"NCT00136825","phase":"PHASE1","title":"Effectiveness of N-acetylcysteine in Treating Cocaine Dependent Individuals - 1","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2003-03","conditions":"Cocaine-Related Disorders","enrollment":17},{"nctId":"NCT02141620","phase":"EARLY_PHASE1","title":"n-Acetylcysteine and Cocaine","status":"COMPLETED","sponsor":"University of Kentucky","startDate":"2014-05","conditions":"Cocaine Abuse, Cocaine Dependence","enrollment":15}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":89,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["NAC"],"phase":"marketed","status":"active","brandName":"Cocaine N-acetylcysteine","genericName":"Cocaine N-acetylcysteine","companyName":"Hospital de Clinicas de Porto Alegre","companyId":"hospital-de-clinicas-de-porto-alegre","modality":"Small molecule","firstApprovalDate":"","aiSummary":"N-acetylcysteine replenishes glutathione stores and provides antioxidant protection to counteract cocaine-induced oxidative stress and toxicity. Used for Cocaine use disorder and cocaine toxicity mitigation.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}